Template:HIV post-exposure prophylaxis regimens
Revisión del 16:16 22 may 2016 de Ostermayer (discusión | contribs.) (Created page with "===2 drug Basic<ref name="NEJM">Landovitz RJ, Currier JS. Postexposure prophylaxis for HIV infection. N Eng J Med. 2009 Oct 29; 361(18): 1768-75. [http://www.uphs.upenn.edu/pp...")
2 drug Basic[1]
- Tenofovir-Emtricitabine (Truvada) one tablet (300 mg of tenofovir with 200 mg of emtricitabine) once daily OR
- Zidovudine–lamivudine (Combivir) one tablet (300 mg of zidovudine with 150 mg of lamivudine) twice daily
- this regimen is preferred in pregancy
3 drug Expanded[1]
- Ritonavir–lopinavir (Kaletra) PLUS either tenofovir–emtricitabine or zidovudine–lamivudine)
- Two tablets (50 mg of ritonavir with 200 mg of lopinavir per tablet) twice daily, or four tablets once daily
- Ritonavir plus atazanavir (plus either tenofovir–emtricitabine or zidovudine–lamivudine
- 100 mg of ritonavir plus 300 mg of atazanavir once daily
- Ritonavir plus darunavir (plus either tenofovir–emtricitabine or zidovudine–lamivudine)
- 100 mg of ritonavir plus two tablets, each containing 400 mg of darunavir, once daily